We assumed that a better understanding of the JNK signaling pathway and its relationship with PPARγ, NF-κB, PTP1B signaling pathways are necessary for a new drug targeting the treatment of obesity and mood disorders [39]. Here, PPARG is linked to obesity due to melanocortin 4 receptor deficiency.